experimental structures and rationalize their features. 1 undergoes oxidative transformations with CH2Cl2 to cis‐[IrIII(CNMeC)(CH2Cl)Cl2] (7) and with PhICl2 to mer‐[IrIII(CNMeC)Cl3] (8). The ruthenium derivatives trans‐[RuII(CNC)Cl2L] CNC = [2,6‐bis(2,6‐diisopropylphenyl)imidazol‐2‐ylidene]‐pyridine, L = pyridine, 10} and [RuII(CNC)(η2,η2‐nbd)](X)2 . 2L (nbd = 2,5‐norbornadiene, L = CH3CN, X = BF4 11), were
阳离子钳型配合物[Ir I(CN Me C)L] X CN Me C = [2,6-双(2,6-二异丙基苯基)
咪唑-2-亚基] -3,5-二
甲基吡啶,L = CO,X = PF 6 4;L = CH 3 CN,X = PF 6 5;L =
吡啶,X = BAr F 4,Ar F = 3,5-双三
氟甲基-苯基6 },是通过置换
氯配体从[Ir I(CN Me C)Cl](1)中获得的表征。配合物4和5采用方形平面,面内扭曲几何形状,而在6中
金属环境呈显着的
金字塔形。4和6中阳离子的理论计算重现了实验结构并使其特征合理化。1层进行氧化,用CH变换2
氯2至顺式- [
铱III(CN我C)(CH 2 Cl)的
氯2 ](7)中并用PhICl 2至聚体-的[Ir III(CN我C)
氯3 ](8)。
钌衍
生物反式[Ru II(CNC)
氯2 L] CNC = [2,6-双(2,6-二异丙基苯基)
咪唑-2-亚基]